DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Neomycin sulfateis the generic ingredient in thirteen branded drugs marketed by Pharmacia And Upjohn, X Gen Pharms, Pfizer, Bristol Myers Squibb, Lannett, Lannett Co Inc, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Xgen Pharms, Glaxosmithkline, Alcon, Watson Labs, Monarch Pharms, Allergan, Merck, Savage Labs, Fougera, and Pharmaderm, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.
There are nineteen drug master file entries for neomycin sulfate. Four suppliers are listed for this compound.
Recent Clinical Trials for neomycin sulfate
Identify potential brand extensions & 505(b)(2) entrants
|Emory University||Phase 4|
|Ache Laboratorios Farmaceuticos S.A.||Phase 3|
|European Commission||Phase 2|
Pharmacology for neomycin sulfate
|Drug Class||Aminoglycoside Antibacterial |
Medical Subject Heading (MeSH) Categories for neomycin sulfate
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.